Advertisement

Topics

FS-Elliott Company Profile

07:52 EDT 21st June 2018 | BioPortfolio

FS-Elliott is a global leader in the engineering and manufacturing of oil-free, centrifugal air compressors with operations in over 90 countries. Building on a 50-year tradition of excellence, FS-Elliott combines an unwavering commitment to quality with the desire for advancing technology to bring value to our customers, allowing them to increase their productivity and lower system operating costs. For more information, please visit www.fs-elliott.com.


News Articles [29 Associated News Articles listed on BioPortfolio]

Elliott Management Outlines Concerns With athenahealth’s Lack of Engagement Over Acquisition Bid in Letter

On Tuesday, Elliott Management Corporation (“Elliott”) released a letter to the Board of Directors of athenahealth, Inc. regarding Elliott’s proposal to acquire athenahealth for $160 per share ...

Elliott Squires is recognized by Continental Who's Who

GREENVILLE, N.C., April 2, 2018/PRNewswire/ -- Elliott Squiresis recognized by Continental Who's Who as a Pinnacle Lifetime Member in the field of Read more...

Will athenahealth accept Elliott Management’s hefty buyout offer?

After Elliott Management sent a third letter to athenahealth urging it to consider the offer, the EHR vendor retorted with a statement of its own, noting it will take its time in evaluating the bid.

Elliott Management Makes $7 Billion Takeover Offer for athenahealth

Investment firm Elliott Management has proposed acquiring Watertown, Mass.-based health IT vendor athenahealth in a deal worth nearly $7 billion.

Activist investor Elliott Management makes $6.9B unsolicited offer for athenahealth

In a letter to athenahealth’s board of directors, Elliott Management Partner Jesse Cohn makes his firm’s case for why the company would be better off as a private business.

STADA Arzneimittel AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

STADA Arzneimittel AG 12.01.2018 / 15:21 Dissemination of a Voting Rights Announcement transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this...

Elliott makes $7B all-cash bid for Athenahealth

Elliott makes $7B all-cash bid for Athenahealth nleider Mon, 05/07/2018 - 14:44 Teaser Media

Correction of a release from 12.01.2018, 15:21 CET/CEST - STADA Arzneimittel AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

STADA Arzneimittel AG 29.01.2018 / 15:04 Dissemination of a Voting Rights Announcement transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this...

Drugs and Medications [0 Results]

None

PubMed Articles [6 Associated PubMed Articles listed on BioPortfolio]

Correction to: Scaling Safe Access to Fecal Microbiota Transplantation: Past, Present, and Future.

In the original version of this article, author Ryan Elliott's name was misspelled as Ryan Eliott. The correct spelling of the name is Ryan Elliott.

Aquagenic Wrinkling of the Palms in Patients with Cystic Fibrosis.

Aquagenic wrinkling of the palms (AWP) is a condition characterized by oedema, confluent white papules and excessive wrinkling of the palms after few minutes exposure to water. The phenomenon may be a...

Dr. elliot f. ellis: initiating personalized asthma management in children.

Elliot F. Ellis is indeed a giant in the field of allergy and immunology. From his leadership role in developing a pediatric allergy and immunology fellowship at National Jewish Health and his seminal...

Testing the effects of explicit and implicit bidimensional attitudes on objectively measured speeding behaviour.

Bidimensional attitudes have been shown to independently predict behaviour, with the positive dimension of attitude being a stronger predictor of behaviour than the negative dimension (e.g., Elliott, ...

The bioavailability of different dissolved organic nitrogen compounds for the freshwater algae Raphidocelis subcapitata.

Understanding which factors affect the algal bioavailability of dissolved organic nitrogen (DON) compounds in natural surface waters is important for our understanding of nutrient biogeochemistry and ...

Clinical Trials [2 Associated Clinical Trials listed on BioPortfolio]

Brain Development Research Program

Dr. Elliott Sherr and his collaborators at University of California, San Francisco (UCSF) are studying the genetic causes of disorders of cognition and epilepsy, in particular disorders of...

A Two-arm Efficacy and Safety Study of Deferiprone in Patients With Pantothenate Kinase-associated Neurodegeneration (PKAN)

A multi-center, placebo controlled, double-blind trial comparing the efficacy and safety of 18 months of treatment with deferiprone versus placebo in patients with PKAN. This investigator...

Companies [8 Associated Companies listed on BioPortfolio]

FS-Elliott

FS-Elliott is a global leader in the engineering and manufacturing of oil-free, centrifugal air compressors with operations in over 90 countries. Building on a 50-year tradition o...

David Elliott

Elliott Advisors

David Elliott Healing

Elliott Management Corporation

More Information about "FS-Elliott" on BioPortfolio

We have published hundreds of FS-Elliott news stories on BioPortfolio along with dozens of FS-Elliott Clinical Trials and PubMed Articles about FS-Elliott for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of FS-Elliott Companies in our database. You can also find out about relevant FS-Elliott Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record